ITI Inc (ITCI) was Initiated by Piper Jaffray to “Overweight”. Piper Jaffray advised their investors in a research report released on Jun 2, 2016.
On the company’s financial health, ITI Inc reported $-0.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.17 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $-0.81.Analysts expectations of $ .02.
ITI Inc opened for trading at $38.6 and hit $40.05 on the upside on Wednesday, eventually ending the session at $39.45, with a gain of 1.94% or 0.75 points. The heightened volatility saw the trading volume jump to 3,30,791 shares. Company has a market cap of $1,706 M.
In a different news, on Apr 20, 2016, Rory B Riggs (director) purchased 28,571 shares at $17.50 per share price. According to the SEC, on Dec 15, 2015, Sharon Mates (Chairman, President & CEO) sold 51,500 shares at $54.29 per share price. On Dec 15, 2015, Lawrence J. Hineline (VP of Finance CFO) sold 45,000 shares at $51.56 per share price, according to the Form-4 filing with the securities and exchange commission.
ITI Inc. is a United States-based company. The Company is a subsidiary of Intra-Cellular Therapies Inc.